Board proposes dividend increase to CHF 9.70. If approved by shareholders, this would be the 38th consecutive dividend increase.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Genentech announces INAVO120 study met key secondary endpoint
- Sarepta announces topline results from EMBARK study
- Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
- Drugmakers to push Trump to pause price negotiations, Bloomberg reports
- Roche receives FDA clearance for B-cell lymphoma diagnostic test